Literature DB >> 21401656

Totally subcutaneous implantable cardioverter defibrillator with an alternative, right parasternal, electrode placement.

Sven Zumhagen1, Andrew A Grace, Stephen O'Connor, Andreas Löher, Julia Köbe, Lars Eckardt, Eric Schulze-Bahr.   

Abstract

The totally subcutaneous implantable cardioverter-defibrillator (S-ICD) is an entirely novel defibrillation device that avoids the direct contact of device electrodes with the heart and the cardiovascular system. Here, we present a particular case of a young woman with congenital long-QT syndrome in which we implanted the electrode alternatively, right parasternally. This decision was based on the thoracic anatomy of the patient and on findings of a model of S-ICD electrodes in an adult torso. In conclusion, in some patients an alternative subcutaneous electrode position may be carefully considered but should not be taken to outweigh the standard left-sided placement. ©2011, The Authors. Journal compilation ©2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21401656     DOI: 10.1111/j.1540-8159.2011.03043.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  8 in total

1.  Right versus left parasternal electrode position in the entirely subcutaneous ICD.

Authors:  Markus Bettin; Dirk Dechering; Gerrit Frommeyer; Robert Larbig; Andreas Löher; Florian Reinke; Julia Köbe; Lars Eckardt
Journal:  Clin Res Cardiol       Date:  2017-12-28       Impact factor: 5.460

2.  [Current status and problems of the entirely subcutaneous ICD (S-ICD®)].

Authors:  F Reinke; A Löher; J Köbe; L Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-09

Review 3.  [Subcutaneous implantable cardioverter-defibrillator : Current status and perspectives].

Authors:  Philipp Niehues; Gerrit Frommeyer; Florian Reinke; Lars Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-10-10

Review 4.  Recent advances in the entirely subcutaneous ICD System.

Authors:  Markus Bettin; Florian Reinke; Benjamin Rath; Julia Köbe; Lars Eckardt
Journal:  F1000Prime Rep       Date:  2015-04-02

5.  Right-sided subcutaneous implantable cardioverter-defibrillator placement in a patient with dextrocardia, tetralogy of Fallot, and conduction disease.

Authors:  Scott R Ceresnak; Kara S Motonaga; Ian S Rogers; Mohan N Viswanathan
Journal:  HeartRhythm Case Rep       Date:  2015-06-12

6.  Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes.

Authors:  Pier D Lambiase; Lars Eckardt; Dominic A Theuns; Timothy R Betts; Andreas L Kyriacou; Elizabeth Duffy; Reinoud Knops
Journal:  Heart Rhythm O2       Date:  2020-10-28

7.  Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction.

Authors:  Daniela Malan; Miao Zhang; Birgit Stallmeyer; Jovanca Müller; Bernd K Fleischmann; Eric Schulze-Bahr; Philipp Sasse; Boris Greber
Journal:  Basic Res Cardiol       Date:  2016-01-23       Impact factor: 17.165

8.  To the Editor- Strategy for revision of subcutaneous implantable cardioverter-defibrillator following inappropriate shock.

Authors:  Joachim Winter; Stephen O'Connor
Journal:  HeartRhythm Case Rep       Date:  2019-08-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.